Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring

The purpose of this interventional study is to identify which combination of remote monitoring devices (e.g. home spirometry, pulse oximetry, scale, ePROs) is the most feasible (as defined by adherence, retention, and data completeness) and acceptable when used for the detection of clinically significant Interstitial Lung Disease events.

NCT Number	NCT07673237
Lead Sponsor	University of California, San Francisco Collaborators: National Heart, Lung, and Blood Institute (NHLBI), patientMpower Ltd.
Conditions	Fibrotic Interstitial Lung Disease, IPF and PPF, Lung Fibrosis Interstitial
Enrollment	200 participants
Start Date	2026-08-01
Primary Completion	2028-08-01 (estimated)
Study Completion	2028-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-29